shutterstock_1472976248_siberian_art

Siberian Art / Shutterstock.com

4 September 2020BiotechnologyRory O'Neill

LSPN Connect: Protecting biologics at home and abroad

Biologics are playing an increasingly important role in healthcare, but for corporate patent counsel, the differences in rules between the US and Europe are a real cause for concern.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

LSPN 19: PTAB and ‘languishing’ STRONGER Act on 2020 agenda

22 October 2019 While the next Alice or Mayo is unlikely to be handed down next year, there are many slightly less “revolutionary" developments likely to crop up in 2020, according to Charles Larsen, partner at White & Case.

LSPN 19: Mayo has led us down the rabbit hole, says lawyer

26 April 2019 There’s alarm in the scientific community because of how broadly the principles of the Mayo test for section 101 are being used to strike down patents on profound innovations and discoveries.

More on this story

LSPN 19: PTAB and ‘languishing’ STRONGER Act on 2020 agenda

22 October 2019 While the next Alice or Mayo is unlikely to be handed down next year, there are many slightly less “revolutionary" developments likely to crop up in 2020, according to Charles Larsen, partner at White & Case.

LSPN 19: Mayo has led us down the rabbit hole, says lawyer

26 April 2019 There’s alarm in the scientific community because of how broadly the principles of the Mayo test for section 101 are being used to strike down patents on profound innovations and discoveries.

More on this story

LSPN 19: PTAB and ‘languishing’ STRONGER Act on 2020 agenda

22 October 2019 While the next Alice or Mayo is unlikely to be handed down next year, there are many slightly less “revolutionary" developments likely to crop up in 2020, according to Charles Larsen, partner at White & Case.

LSPN 19: Mayo has led us down the rabbit hole, says lawyer

26 April 2019 There’s alarm in the scientific community because of how broadly the principles of the Mayo test for section 101 are being used to strike down patents on profound innovations and discoveries.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool